Tiansheng Pharmaceutical Group Co., Ltd. (SZSE: 002872)
Health Care · Pharmaceuticals · CN
CN¥5.30
-0.93% today · +7.5% 1Y
Tiansheng Pharmaceutical Group Co., Ltd. (SZSE: 002872) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $250.71M and employs 1,273 people.
Over the last twelve months the share price has gained 7.5%, trading between 4.32 and 5.81.
Tweenvest scores Tiansheng Pharmaceutical Group Co., Ltd. across four factors: quality 55/100, value 49/100, growth 0/100. Its strongest factor is quality.
002872 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $250.71M
- Revenue (TTM)
- $76.92M
- P/E
- —
- EPS
- -0.17
- Dividend yield
- —
- Beta (5Y)
- 0.32
- 52-week high
- CN¥5.81
- 52-week low
- CN¥4.32
- Avg volume (3M)
- —
- Shares outstanding
- 318.00M
- Employees
- 1,273
- Next earnings
- —
About Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co., Ltd. is engaged in the manufacturing and distribution of pharmaceutical products. The company supplies a broad spectrum of medications that address various therapeutic areas, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, oncological, hepatobiliary, hematological, surgical, and diabetic conditions, among others. This enterprise was established in 2001 and its headquarters are located in Chongqing, China.
- ISIN
- CNE100002QC3
- Founded
- 2001
- Listed since
- May 19, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.